Surge in clinical trials testing psilocybin
Clinical trials testing psilocybin initiated each year as a percentage of total drug trials initiated for psychiatric disorders, sorted by phase (2023 based on planned trials)
Clinical trials testing psilocybin initiated each year as a percentage of total drug trials initiated for psychiatric disorders, sorted by phase (2023 based on planned trials)
